FiercePharmaFrom FiercePharmaGlobal Supply Chain ManagementU.K. Fights EpiPen Shortage by Extending Injector Expiry DatesAs a shortage of epinephrine pens continues to grip the U.K., authorities have agreed to extend the expiration date on a second injector to help ease the situation.October 30, 2018Global Supply Chain ManagementPharma Warns of Drug Supply Disruptions Without a Brexit DealDrugmakers in the EU are warning of drug supply chaos if the U.K. and European Commission can't strike a specific deal covering the approval of medicines before their governmental divorce.November 22, 2017Global Supply Chain ManagementBayer Recalled 1M Alka Seltzer Cartons As Sales in Consumer Health SlidBayer - already struggling with falling consumer health sales - is also contending with a recall. It has been retrieving more than a million cartons of its Alka-Seltzer Original.August 30, 2017Global Supply Chain ManagementProduction Issues Lead to Global Shortage of Hepatitis B VaccineA global shortage of hepatitis B vaccine has developed as both Merck & Co. and GlaxoSmithKline deal with manufacturing issues, leading health agencies in England to ration use to those most at risk.August 22, 2017All LogisticsU.K. Pharmaceutical Manufacturers Will Be Lumped With India, China Upon BrexitThe European Commission has made clear how it intends to treat the U.K.'s active pharmaceutical ingredient (API) industry after that country gives up its EU membership: just like it treats those from China and India.July 10, 2017Global Supply Chain ManagementGSK Recalling Nearly 600,000 Ventolin Inhalers in the U.S.With sales of its respiratory drugs doing well, GlaxoSmithKline has been spending hundreds of millions of dollars to expand manufacturing of several kinds of inhalers. But a glitch at one of its Ventolin inhaler plants has resulted in recalling nearly 600,000 units in the U.S.April 18, 2017Global Supply Chain ManagementMylan Epipen Recall Goes GlobalA recall of potentially malfunctioning EpiPens that Mylan first announced for Europe, Japan and Asia has now gone global, including the U.S., with the company retrieving tens of thousands more. Mylan, however, says it has plenty of replacements to avoid any interruptions in supply.April 17, 2017Business Strategy AlignmentBayer Calls China 'Wild Card' for Its Consumer Health BusinessMore than two years after buying Merck's OTC unit and local player Dihon, bringing together three separate consumer care businesses in China remains a challenge, Bayer said.September 28, 2016Business Strategy Alignment500 Chinese Pharma Companies Registered in U.S., But Quality Continues to Be Stumbling BlockChinese companies now account for more than 50 percent of the global active pharmaceutical ingredient (API) market. It has more than 500 companies registered to sell in the U.S. and 10 times that many serving its own market. But many of those continue to struggle to meet international standards.September 1, 2016All LogisticsIn Wake of Hospira Acquisition, Pfizer Consolidating DCsPfizer has decided that it does not need the legacy distribution sites that it got with the $15bn buyout of Hospira last year and so will close four facilities across the U.S., consolidating distribution into two Pfizer logistics centers next year. In the process it will whack 104 jobs.August 22, 2016Page 1 of 2Next Page
